Mantis takes disparate sources of data to make synthetic datasets that can be used to build so-called "digital twins" of the ...
PSC Biotech partners with Blue Ocean Robotics to distribute the UVD Robot Pharma delivering autonomous UV C disinfection for ...
Half a year after being spurned by the FDA and following deep layoffs, IO Biotech has decided to close its doors for good.
Ambrosia Biosciences is aiming to move the market beyond peptide-based obesity treatments and initiate a trial for its oral ...
While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...
The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force behind this resurgence.
U.S. venture capital firms are no longer waiting for Chinese biotech assets to surface before investing in them — they’re ...
The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing ...
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only ...
Discover the Latest in Research Peptides at Biotech Labz Supply Sebastopol, United States - January 3, 2026 / Biotech ...
CNBC's Angelica Peebles reports the latest news surrounding Big Pharma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results